NCT04101370View on ClinicalTrials.gov

Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 24, 2018

Primary Completion Date

June 20, 2018

Study Completion Date

June 20, 2018

Conditions
Bioequivalence
Interventions
DRUG

Bosentan 125 mg

Single administered dose of Bosentan (125 mg tablet immediate release) in a fasting condition

DRUG

Tracleer 125Mg Tablet

Single administered dose of Tracleer® (125 mg tablet immediate release) in a fasting condition

Trial Locations (1)

150007

Clinical Hospital № 3, Yaroslavl

Sponsors

Lead Sponsor

Geropharm
All Listed Sponsors
lead

Geropharm

INDUSTRY